CHINA & GERMANY
Research driven pharmaceutical company Boehringer Ingelheim, in partnership with Taizhou China Medical City in Jiangsu Province, China, held a ground-breaking ceremony for a veterinary vaccine manufacturing plant at the China Medical City (Taizhou China Medicine High-Tech Development Zone) last week (Friday, 16 August).
US - Controlling swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCV2) and Mycoplasma pneumonia (M. hyo) is one of the the key challenges for producers and veterinarians. During the 2012 World Pork Expo, swine experts discussed the impacts of these diseases, the latest research and effective ways to manage respiratory diseases on modern production farms.
US - The research driven pharmaceutical company Boehringer Ingelheim will expand its global animal health vaccines business. With the completion of a series of major investments at the US site in St. Joseph, Missouri, the company will further enhance its position in the development and supply of vaccines against the most important diseases of pigs.
Boehringer Ingelheim yesterday announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai.
Read and download the posters.
Some highly positive messages about progress in the global fight against the Porcine Reproductive and Respiratory Syndrome have been delivered to the latest Asian PRRSspective Symposium, which was held in November 2017 in Fukuoka, Japan, with the support of the Japanese Association of Swine Veterinarians.
Precision is the future of all food production including pork and prevention is the foundation of precision. In this series of articles, Dr. DiPietre will look at different aspects related with pig production and precision agriculture and what economic impact could they have in our farms.
Get the latest news on Swine Health Subscribe to our newsletter